In patients with inflammatory bowel disease and concomitant primary sclerosing cholangitis (PSC), the risk of colon cancer is particularly high, and it is recommended that such patients begin yearly surveillance as soon as the diagnosis of PSC is made.
If you want to change selection, open document below and click on "Move attachment"
- (no access) - MKSAP_17.pdf, p2626
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|